Erythematous Telangiectatic Rosacea

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Erythematous Telangiectatic Rosacea trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

RecruitingNot Applicable

NCT07343635

The Efficacy and Safety of Anti-inflammation Treatment (Hirudoid Introduction Followed by Yellow Light Therapy) Combined…

The efficacy and safety of anti-inflammation treatment (Hirudoid introduction followed by yellow light therapy) combined with tofacitinib and doxycycline in Chi…

China186 participantsStarted 2026-02-01

Treatment: Doxycycline, Hydroxychloroquine

RecruitingNot Applicable

NCT07106957

Efficacy and Safety Evaluation of CICAPLAST BAUME B5+ on Rosacea Accompanied by Sensitive Skin

In total, 72 eligible research participants were recruited in this 56-day study. The participants were divided into two groups-namely the Experimental Group and…

China72 participantsStarted 2025-06-10

Treatment: CICAPLAST BAUME B5+, Standard cream

All recent trials (3 shown)

CompletedNot Applicable

NCT06908915

Long Pulse 1064 nm Nd:YAG Laser in the Treatment of Erythematotelangiectatic Rosacea and Other Erythematous Telangiectat…

The goal of this clinical study is to assess the effectiveness of Nd:YAG laser 1064 nm in the long pulse mode in the treatment of signs of rosacea including the…

Iraq30 participantsStarted 2023-03-03

Treatment: Nd:YAG laser 1064 nm